share_log

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $10

Benzinga ·  Aug 11, 2023 07:06

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $9 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment